|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
323 Allerton Ave,South San Francisco,California,US
|
|
Alexo Therapeutics is a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint mechanism exploited by cancer cells to evade the immune system. Our lead candidate, ALX148, is a fusion protein that comprises an engineered high affinity CD47 binding domain of SIRPa linked to an inactive Fc region of human immunoglobulin. ALX148 is designed to enhance the efficacy of antibody-based therapies and is in clinical development for a broad range of tumor types. For more information about the company, please visit our website at www.alexotherapeutics.com
|
ALX Oncology Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used ALX Oncology email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact ALX Oncology customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.